Date lodged: 31 January 2018
To ask the Scottish Government what plans it has to work with (a) patient groups and (b) the health sector to establish which managed access schemes and conditional acceptance options will be of greatest benefit.
Answered by: Shona Robison 8 February 2018
Since publication of the Montgomery Review of Access to New Medicines, we have been working closely with relevant partners, stakeholders, patient representatives, the third sector and the pharmaceutical industry to consider the most appropriate and effective way to take forward the recommendations.
I wrote to the Health and Sport Committee on 16 November to provide an update on the Scottish Government’s progress on implementing the recommendations of the Montgomery Review. I will provide a further update to the Committee in the Spring.